Differentiating Inflammatory Pathways in EGPA and SEA
Episode Summary
Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.